Temat: "BIOMARKERS" - OpacWWW

Skocz do pozycji: 1 1.

Tytuł :: Biomarkers for Cancer Cachexia: A Mini Review.
Autorzy :: Cao Z; Department of Biochemistry and Genetics, La Trobe University, Bundoora, VIC 3086, Australia.
Zhao K; Department of Biochemistry and Genetics, La Trobe University, Bundoora, VIC 3086, Australia.; Department of Laboratory Medicine, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Jose I; Department of Biochemistry and Genetics, La Trobe University, Bundoora, VIC 3086, Australia.
Hoogenraad NJ; Department of Biochemistry and Genetics, La Trobe University, Bundoora, VIC 3086, Australia.; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, School of Cancer Medicine, La Trobe University, Melbourne, VIC 3084, Australia.
Osellame LD; Department of Biochemistry and Genetics, La Trobe University, Bundoora, VIC 3086, Australia.; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, School of Cancer Medicine, La Trobe University, Melbourne, VIC 3084, Australia.; Pokaż więcej
Źródło :: International journal of molecular sciences [Int J Mol Sci] 2021 Apr 26; Vol. 22 (9). Date of Electronic Publication: 2021 Apr 26.
Typ publikacji :: Journal Article; Review
MeSH Terms :: Biomarkers, Tumor*/blood
Biomarkers, Tumor*/metabolism
Cachexia*/diagnosis
Cachexia*/physiopathology
Neoplasms/*complications
Biomarkers/blood ; Biomarkers/metabolism ; Humans ; Muscle, Skeletal/physiopathology ; Risk Factors ; Weight Loss
: Czasopismo naukowe

Szczegóły Pełny tekst

Skocz do pozycji: 2 2.

Tytuł :: Molecular Targeting of H/MDM-2 Oncoprotein in Human Colon Cancer Cells and Stem-like Colonic Epithelial-derived Progenitor Cells.
Autorzy :: Thadi A; Division of Surgical Oncology, Department of Surgery, Drexel University College of Medicine, Philadelphia, PA, U.S.A.
Morano WF; Division of Surgical Oncology, Department of Surgery, Drexel University College of Medicine, Philadelphia, PA, U.S.A.
Khalili M; Division of Surgical Oncology, Department of Surgery, Drexel University College of Medicine, Philadelphia, PA, U.S.A.
Babcock BD; Division of Surgical Oncology, Department of Surgery, Drexel University College of Medicine, Philadelphia, PA, U.S.A.
Shaikh MF; Division of Surgical Oncology, Department of Surgery, Drexel University College of Medicine, Philadelphia, PA, U.S.A.
Foster DS; Division of Surgical Oncology, Department of Surgery, Drexel University College of Medicine, Philadelphia, PA, U.S.A.
Piazza Y; Department of Pathology and Laboratory Medicine, Drexel University College of Medicine, Philadelphia, PA, U.S.A.
Gleeson EM; Division of Surgical Oncology, Department of Surgery, Drexel University College of Medicine, Philadelphia, PA, U.S.A.
Goldstein E; Division of Surgical Oncology, Department of Surgery, Drexel University College of Medicine, Philadelphia, PA, U.S.A.
Steele L; Division of Surgical Oncology, Department of Surgery, Drexel University College of Medicine, Philadelphia, PA, U.S.A.
Campbell PM; Cancer Signaling and Epigenetics Program, The Marvin and Concetta Greenberg Pancreatic Cancer Institute Fox Chase Cancer Center, Philadelphia, PA, U.S.A.
Lin BO; Department of Pathology and Laboratory Medicine, SUNY Downstate Medical Center, Brooklyn, NY, U.S.A.; .
Pincus MR; Department of Pathology and Laboratory Medicine, SUNY Downstate Medical Center, Brooklyn, NY, U.S.A.; .
Bowne WB; Division of Surgical Oncology, Department of Surgery, Drexel University College of Medicine, Philadelphia, PA, U.S.A.; .; Department of Surgery, Thomas Jefferson University, Philadelphia, PA, U.S.A.; Pokaż więcej
Źródło :: Anticancer research [Anticancer Res] 2021 Jan; Vol. 41 (1), pp. 27-42.
Typ publikacji :: Journal Article
MeSH Terms :: Biomarkers, Tumor*
Antineoplastic Agents/*pharmacology
Colonic Neoplasms/*etiology
Neoplastic Stem Cells/*drug effects
Neoplastic Stem Cells/*metabolism
Proto-Oncogene Proteins c-mdm2/*antagonists & inhibitors
Proto-Oncogene Proteins c-mdm2/*metabolism
Animals ; Antineoplastic Agents/therapeutic use ; Biomarkers ; Cell Line, Tumor ; Colonic Neoplasms/drug therapy ; Colonic Neoplasms/metabolism ; Colonic Neoplasms/pathology ; Disease Models, Animal ; Humans ; Hyaluronan Receptors/metabolism ; Mice ; Molecular Targeted Therapy ; Necrosis/pathology ; Protein Binding ; Tumor Suppressor Protein p53/pharmacology ; Xenograft Model Antitumor Assays
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 3 3.

Tytuł :: PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma.
Autorzy :: Feng H; Department of Laboratory, Tianjin Medical University Cancer Institute and Hospital, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Huanhuxi Road, Hexi District, Tianjin, 300060, China.
Li B; Department of Pharmacy, Tianjin Medical University Cancer Institute and Hospital, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin, China.
Li Z; Department of Laboratory, Tianjin Medical University Cancer Institute and Hospital, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Huanhuxi Road, Hexi District, Tianjin, 300060, China.
Wei Q; Department of Laboratory, Tianjin Medical University Cancer Institute and Hospital, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Huanhuxi Road, Hexi District, Tianjin, 300060, China.
Ren L; Department of Laboratory, Tianjin Medical University Cancer Institute and Hospital, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Huanhuxi Road, Hexi District, Tianjin, 300060, China. .; Pokaż więcej
Źródło :: BMC cancer [BMC Cancer] 2021 Apr 13; Vol. 21 (1), pp. 401. Date of Electronic Publication: 2021 Apr 13.
Typ publikacji :: Journal Article
MeSH Terms :: Biomarkers, Tumor*
alpha-Fetoproteins*
Biomarkers/*blood
Carcinoma, Hepatocellular/*blood
Carcinoma, Hepatocellular/*diagnosis
Liver Neoplasms/*blood
Liver Neoplasms/*diagnosis
Protein Precursors/*blood
Carcinoma, Hepatocellular/therapy ; Disease Management ; Enzyme-Linked Immunosorbent Assay ; Female ; Humans ; Liquid Biopsy ; Liver Neoplasms/therapy ; Male ; Neoplasm Metastasis ; Neoplasm Staging ; Prognosis ; Prothrombin ; ROC Curve ; Reproducibility of Results ; Sensitivity and Specificity ; Treatment Outcome
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 4 4.

Tytuł :: Stereotactic radiotherapy for hepatocellular carcinoma induced by hepatitis C and the relationships of changes in carbohydrate antigen 19-9 with AFP and PIVKA-II.
Autorzy :: Maebayashi T; Department of Radiology, Nihon University School of Medicine, 30-1, Oyaguchi Kami-cho Itabashi-ku, 173-8610 Tokyo, Japan. Electronic address: .
Ishibashi N; Department of Radiology, Nihon University School of Medicine, 30-1, Oyaguchi Kami-cho Itabashi-ku, 173-8610 Tokyo, Japan. Electronic address: .
Aizawa T; Department of Radiology, Nihon University School of Medicine, 30-1, Oyaguchi Kami-cho Itabashi-ku, 173-8610 Tokyo, Japan. Electronic address: .
Sakaguchi M; Department of Radiology, Nihon University School of Medicine, 30-1, Oyaguchi Kami-cho Itabashi-ku, 173-8610 Tokyo, Japan. Electronic address: .
Okada M; Department of Radiology, Nihon University School of Medicine, 30-1, Oyaguchi Kami-cho Itabashi-ku, 173-8610 Tokyo, Japan. Electronic address: .; Pokaż więcej
Źródło :: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique [Cancer Radiother] 2021 May; Vol. 25 (3), pp. 242-248. Date of Electronic Publication: 2021 Jan 14.
Typ publikacji :: Journal Article
MeSH Terms :: Biomarkers/*blood
CA-19-9 Antigen/*blood
Carcinoma, Hepatocellular/*radiotherapy
Hepatitis C, Chronic/*complications
Liver Neoplasms/*radiotherapy
Protein Precursors/*blood
alpha-Fetoproteins/*metabolism
Aged ; Aged, 80 and over ; Biomarkers, Tumor/blood ; Carcinoma, Hepatocellular/blood ; Carcinoma, Hepatocellular/pathology ; Carcinoma, Hepatocellular/virology ; Female ; Hepatitis C, Chronic/virology ; Humans ; Liver Cirrhosis/complications ; Liver Cirrhosis/virology ; Liver Neoplasms/blood ; Liver Neoplasms/pathology ; Liver Neoplasms/virology ; Male ; Middle Aged ; Neoplasm Recurrence, Local/blood ; Prothrombin
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 5 5.

Tytuł :: Molecular Characteristics of Lymphocyte-predominant Triple-negative Breast Cancer.
Autorzy :: Sasaki R; Department of Breast Oncology, Juntendo University School of Medicine, Tokyo, Japan.
Horimoto Y; Department of Breast Oncology, Juntendo University School of Medicine, Tokyo, Japan; .; Department of Human Pathology, Juntendo University School of Medicine, Tokyo, Japan.
Yanai Y; Department of Human Pathology, Juntendo University School of Medicine, Tokyo, Japan.
Kurisaki-Arakawa A; Department of Human Pathology, Juntendo University School of Medicine, Tokyo, Japan.
Arakawa A; Department of Human Pathology, Juntendo University School of Medicine, Tokyo, Japan.
Nakai K; Department of Breast Oncology, Juntendo University School of Medicine, Tokyo, Japan.
Saito M; Department of Breast Oncology, Juntendo University School of Medicine, Tokyo, Japan.
Saito T; Department of Human Pathology, Juntendo University School of Medicine, Tokyo, Japan.; Pokaż więcej
Źródło :: Anticancer research [Anticancer Res] 2021 Apr; Vol. 41 (4), pp. 2133-2140.
Typ publikacji :: Journal Article
MeSH Terms :: Biomarkers, Tumor/*genetics
Lymphocytes, Tumor-Infiltrating/*metabolism
Triple Negative Breast Neoplasms/*diagnosis
Triple Negative Breast Neoplasms/*genetics
Adult ; Aged ; Aged, 80 and over ; B7-H1 Antigen/genetics ; B7-H1 Antigen/metabolism ; Biomarkers, Pharmacological/analysis ; Biomarkers, Pharmacological/metabolism ; Biomarkers, Tumor/analysis ; Biomarkers, Tumor/metabolism ; DNA Copy Number Variations ; DNA Mutational Analysis/methods ; Gene Expression Regulation, Neoplastic ; High-Throughput Nucleotide Sequencing ; Humans ; Immune Checkpoint Inhibitors/therapeutic use ; Loss of Heterozygosity ; Lymphocyte Count ; Lymphocytes/metabolism ; Lymphocytes/pathology ; Lymphocytes, Tumor-Infiltrating/pathology ; Middle Aged ; Mutation ; PTEN Phosphohydrolase/genetics ; PTEN Phosphohydrolase/metabolism ; Polymorphism, Single Nucleotide ; Prognosis ; Transcriptome ; Treatment Outcome ; Triple Negative Breast Neoplasms/drug therapy ; Triple Negative Breast Neoplasms/metabolism
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 6 6.

Tytuł :: Predictive Biomarkers of Immune Checkpoint Inhibitors-Related Toxicities.
Autorzy :: Xu Y; Cancer Center, Renmin Hospital of Wuhan University, Wuhan, China.
Fu Y; Department of Oncology, Xiangyang Hospital, Hubei University of Chinese Medicine, Xiangyang, China.
Zhu B; Institute of Cancer, Xinqiao Hospital, Army Medical University, Chongqing, China.
Wang J; Department of Oncology, The First Affiliated Hospital of Shandong First Medical University, Jinan, China.
Zhang B; Cancer Center, Renmin Hospital of Wuhan University, Wuhan, China.; Pokaż więcej
Źródło :: Frontiers in immunology [Front Immunol] 2020 Oct 06; Vol. 11, pp. 2023. Date of Electronic Publication: 2020 Oct 06 (Print Publication: 2020).
Typ publikacji :: Journal Article; Review
MeSH Terms :: Biomarkers*/blood
Antineoplastic Agents, Immunological/*adverse effects
Immune Checkpoint Inhibitors/*adverse effects
Molecular Targeted Therapy/*adverse effects
Neoplasms/*diagnosis
Neoplasms/*drug therapy
Animals ; Antineoplastic Agents, Immunological/administration & dosage ; Antineoplastic Agents, Immunological/therapeutic use ; Biomarkers, Tumor ; Humans ; Immune Checkpoint Inhibitors/administration & dosage ; Immune Checkpoint Inhibitors/therapeutic use ; Immune Checkpoint Proteins/genetics ; Liquid Biopsy ; Molecular Targeted Therapy/methods ; Neoplasms/etiology ; Neoplasms/mortality ; Organ Specificity ; Prognosis ; Tumor Microenvironment
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 7 7.

Tytuł :: Multivariable Prediction Model for Biochemical Response to First-Generation Somatostatin Receptor Ligands in Acromegaly.
Autorzy :: Coopmans EC; Department of Medicine, Endocrinology section, Pituitary Center Rotterdam, Erasmus University Medical Center, Rotterdam, the Netherlands.
Korevaar TIM; Department of Medicine, Endocrinology section, Pituitary Center Rotterdam, Erasmus University Medical Center, Rotterdam, the Netherlands.
van Meyel SWF; Department of Medicine, Endocrinology section, Pituitary Center Rotterdam, Erasmus University Medical Center, Rotterdam, the Netherlands.
Daly AF; Endocrinologie Centre Hospitalier Universitaire de Liège, Domaine Universitaire du Sart-Tilman, Liège, Belgium.
Chanson P; Assistance Publique-Hôpitaux de Paris, Hôpital de Bicêtre, Service d'Endocrinologie et des Maladies de la Reproduction, Centre de Référence des Maladies Rares de l'Hypophyse, Le Kremlin Bicêtre, France.; Université Paris-Saclay, Univ. Paris-Sud, Inserm, Signalisation Hormonale, Physiopathologie Endocrinienne et Métabolique, Le Kremlin-Bicêtre, France.
Brue T; Aix-Marseille Université, CNRS, Marseille, France.; APHM, Hôpital Conception, Service d'Endocrinologie, Diabète et Maladies Métaboliques, Centre de Référence des Maladies Rares d'Origine Hypophysaire, Marseille, France.
Delemer B; Department of Endocrinology, Diabetes, and Nutrition, University Hospital of Reims, Reims, France.
Hána V; 3rd Department of Internal Medicine, First Medical Faculty, Charles University, Prague, Czech Republic.
Colao A; Dipartimento di Medicina Clinica e Chirurgia, Università Federico II di Napoli, Naples, Italy.
Carvalho D; Department of Endocrinology, Diabetes and Metabolism Section and Instituto de Investigação e Inovação em Saúde, University of Porto, Centro Hospitalar S. João, Porto, Portugal.
Jaffrain-Rea ML; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila and Neuromed, IRCCS, Pozzilli, Italy.
Stalla GK; Clinical Neuroendocrinology, Max-Planck-Institute of Psychiatry, Munich, Germany.
Fajardo-Montañana C; Servicio de Endocrinología, Hospital Universitario La Ribera, Valencia, Spain.
Beckers A; Endocrinologie Centre Hospitalier Universitaire de Liège, Domaine Universitaire du Sart-Tilman, Liège, Belgium.
van der Lely AJ; Department of Medicine, Endocrinology section, Pituitary Center Rotterdam, Erasmus University Medical Center, Rotterdam, the Netherlands.
Petrossians P; Endocrinologie Centre Hospitalier Universitaire de Liège, Domaine Universitaire du Sart-Tilman, Liège, Belgium.
Neggers SJCMM; Department of Medicine, Endocrinology section, Pituitary Center Rotterdam, Erasmus University Medical Center, Rotterdam, the Netherlands.; Pokaż więcej
Źródło :: The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2020 Sep 01; Vol. 105 (9).
Typ publikacji :: Journal Article; Meta-Analysis; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :: Biomarkers, Pharmacological*/analysis
Biomarkers, Pharmacological*/metabolism
Models, Theoretical*
Acromegaly/*drug therapy
Receptors, Somatostatin/*agonists
Somatostatin/*analogs & derivatives
Acromegaly/blood ; Acromegaly/diagnosis ; Adult ; Biomarkers/analysis ; Biomarkers/metabolism ; Cohort Studies ; Europe ; Female ; Human Growth Hormone/blood ; Humans ; Insulin-Like Growth Factor I/metabolism ; Ligands ; Male ; Middle Aged ; Multivariate Analysis ; Octreotide/therapeutic use ; Peptides, Cyclic/therapeutic use ; Prognosis ; Retrospective Studies ; Somatostatin/therapeutic use ; Treatment Outcome
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 8 8.

Tytuł :: Cancer Stem Cells-Origins and Biomarkers: Perspectives for Targeted Personalized Therapies.
Autorzy :: Walcher L; Department of Immunology, Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany.
Kistenmacher AK; Department of Immunology, Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany.
Suo H; Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.
Kitte R; Department of Immunology, Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany.
Dluczek S; Department of Immunology, Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany.
Strauß A; Department of Immunology, Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany.
Blaudszun AR; Department of Immunology, Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany.
Yevsa T; Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.
Fricke S; Department of Immunology, Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany.
Kossatz-Boehlert U; Department of Immunology, Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany.; Pokaż więcej
Źródło :: Frontiers in immunology [Front Immunol] 2020 Aug 07; Vol. 11, pp. 1280. Date of Electronic Publication: 2020 Aug 07 (Print Publication: 2020).
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms :: Biomarkers*
Neoplasms/*etiology
Neoplasms/*metabolism
Neoplastic Stem Cells/*metabolism
Animals ; Biomarkers, Tumor ; Cellular Senescence ; Combined Modality Therapy ; Disease Management ; Disease Progression ; Disease Susceptibility ; Drug Resistance, Neoplasm ; Humans ; Immunotherapy, Adoptive ; Molecular Diagnostic Techniques ; Molecular Targeted Therapy ; Neoplasms/diagnosis ; Neoplasms/therapy ; Neoplastic Stem Cells/drug effects ; Neoplastic Stem Cells/pathology ; Organ Specificity ; Precision Medicine/methods ; Prognosis
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 9 9.

Tytuł :: Impact of RAS mutations on the immune infiltrate of colorectal liver metastases: A preliminary study.
Autorzy :: Polidoro MA; Hepatobiliary Immunopathology Laboratory, Humanitas Clinical and Research Center-IRCCS, Rozzano, Milan, Italy.
Milana F; Department of Hepatobiliary and General Surgery, Humanitas Clinical and Research Center-IRCCS, Rozzano, Milan, Italy.
Soldani C; Hepatobiliary Immunopathology Laboratory, Humanitas Clinical and Research Center-IRCCS, Rozzano, Milan, Italy.
Franceschini B; Hepatobiliary Immunopathology Laboratory, Humanitas Clinical and Research Center-IRCCS, Rozzano, Milan, Italy.
Anselmo A; Flow Cytometry Core, Humanitas Clinical and Research Center-IRCCS, Rozzano, Milan, Italy.
Colombo FS; Flow Cytometry Core, Humanitas Clinical and Research Center-IRCCS, Rozzano, Milan, Italy.
Di Tommaso L; Department of Pathology, Humanitas Clinical and Research Center-IRCCS, Rozzano, Milan, Italy.; Department of Biomedical Science, Humanitas University, Rozzano, Milan, Italy.
Cimino M; Department of Hepatobiliary and General Surgery, Humanitas Clinical and Research Center-IRCCS, Rozzano, Milan, Italy.
Carnevale S; Department of Biomedical Science, Humanitas University, Rozzano, Milan, Italy.
Lleo A; Hepatobiliary Immunopathology Laboratory, Humanitas Clinical and Research Center-IRCCS, Rozzano, Milan, Italy.; Department of Biomedical Science, Humanitas University, Rozzano, Milan, Italy.; Department of Internal Medicine and Hepatology, Humanitas Clinical and Research Center-IRCCS, Rozzano, Milan, Italy.
Jaillon S; Department of Biomedical Science, Humanitas University, Rozzano, Milan, Italy.
Torzilli G; Department of Hepatobiliary and General Surgery, Humanitas Clinical and Research Center-IRCCS, Rozzano, Milan, Italy.; Department of Biomedical Science, Humanitas University, Rozzano, Milan, Italy.
Donadon M; Hepatobiliary Immunopathology Laboratory, Humanitas Clinical and Research Center-IRCCS, Rozzano, Milan, Italy.; Department of Biomedical Science, Humanitas University, Rozzano, Milan, Italy.; Pokaż więcej
Źródło :: Journal of leukocyte biology [J Leukoc Biol] 2020 Aug; Vol. 108 (2), pp. 715-721. Date of Electronic Publication: 2020 Feb 28.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Biomarkers, Tumor*
Mutation*
Colorectal Neoplasms/*genetics
Colorectal Neoplasms/*pathology
Liver Neoplasms/*immunology
Liver Neoplasms/*secondary
Proto-Oncogene Proteins p21(ras)/*genetics
Adult ; Aged ; Biomarkers ; Female ; Humans ; Immunohistochemistry ; Liver Neoplasms/mortality ; Liver Neoplasms/pathology ; Male ; Middle Aged ; Neoplasm Staging ; Prognosis ; Tumor Microenvironment/genetics ; Tumor Microenvironment/immunology
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 10 10.

Tytuł :: Banded tetra (Astyanax aeneus) as bioindicator of trace metals in aquatic ecosystems of the Yucatan Peninsula, Mexico: Experimental biomarkers validation and wild populations biomonitoring.
Autorzy :: Hinojosa-Garro D; Laboratorio en Ecología Acuática y Monitoreo Ambiental, CEDESU, Universidad Autónoma de Campeche, Av. Héroe de Nacozari No. 480, 24070, San Francisco de Campeche, Campeche, Mexico.
Osten JR; Instituto EPOMEX, Universidad Autónoma de Campeche, Av. Héroe de Nacozari No. 480, 24070, San Francisco de Campeche, Campeche, Mexico.
Dzul-Caamal R; Instituto EPOMEX, Universidad Autónoma de Campeche, Av. Héroe de Nacozari No. 480, 24070, San Francisco de Campeche, Campeche, Mexico. Electronic address: .; Pokaż więcej
Źródło :: Ecotoxicology and environmental safety [Ecotoxicol Environ Saf] 2020 Jun 01; Vol. 195, pp. 110477. Date of Electronic Publication: 2020 Mar 19.
Typ publikacji :: Journal Article
MeSH Terms :: Characiformes*/metabolism
Environmental Biomarkers*
Metals/*toxicity
Water Pollutants, Chemical/*toxicity
Acetylcholinesterase/metabolism ; Animals ; Biological Monitoring ; Biomarkers ; Catalase/metabolism ; Copper/toxicity ; Ecosystem ; Glutathione Transferase/metabolism ; Lipid Peroxidation/drug effects ; Metallothionein/metabolism ; Metals/analysis ; Mexico ; Muscles/drug effects ; Muscles/enzymology ; Muscles/metabolism ; Oxidative Stress ; Water Pollutants, Chemical/analysis
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 11 11.

Tytuł :: A neuroimaging biomarker for striatal dysfunction in schizophrenia.
Autorzy :: Li A; Brainnetome Center and National Laboratory of Pattern Recognition, Institute of Automation, Chinese Academy of Sciences, Beijing, China.; School of Artificial Intelligence, University of Chinese Academy of Sciences, Beijing, China.; Center for Excellence in Brain Science and Intelligence Technology, Chinese Academy of Sciences, Shanghai, China.
Zalesky A; Melbourne Neuropsychiatry Centre, Department of Psychiatry, University of Melbourne and Melbourne Health, Melbourne, Victoria, Australia.; Department of Biomedical Engineering, University of Melbourne, Melbourne, Victoria, Australia.
Yue W; Institute of Mental Health, Peking University Sixth Hospital, Beijing, China.; Key Laboratory of Mental Health, Ministry of Health, and National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Beijing, China.
Howes O; Psychiatric Imaging Group, MRC London Institute of Medical Sciences (Imperial College London), Hammersmith Hospital, London, UK.; Institute of Psychiatry, King's College London, London, UK.
Yan H; Institute of Mental Health, Peking University Sixth Hospital, Beijing, China.; Key Laboratory of Mental Health, Ministry of Health, and National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Beijing, China.
Liu Y; Brainnetome Center and National Laboratory of Pattern Recognition, Institute of Automation, Chinese Academy of Sciences, Beijing, China.; School of Artificial Intelligence, University of Chinese Academy of Sciences, Beijing, China.; Center for Excellence in Brain Science and Intelligence Technology, Chinese Academy of Sciences, Shanghai, China.
Fan L; Brainnetome Center and National Laboratory of Pattern Recognition, Institute of Automation, Chinese Academy of Sciences, Beijing, China.; School of Artificial Intelligence, University of Chinese Academy of Sciences, Beijing, China.; Center for Excellence in Brain Science and Intelligence Technology, Chinese Academy of Sciences, Shanghai, China.
Whitaker KJ; Department of Psychiatry, University of Cambridge, Cambridge, UK.; The Alan Turing Institute, British Library, London, UK.
Xu K; Brainnetome Center and National Laboratory of Pattern Recognition, Institute of Automation, Chinese Academy of Sciences, Beijing, China.; School of Artificial Intelligence, University of Chinese Academy of Sciences, Beijing, China.
Rao G; Brainnetome Center and National Laboratory of Pattern Recognition, Institute of Automation, Chinese Academy of Sciences, Beijing, China.; School of Artificial Intelligence, University of Chinese Academy of Sciences, Beijing, China.; Center for Excellence in Brain Science and Intelligence Technology, Chinese Academy of Sciences, Shanghai, China.
Li J; Brainnetome Center and National Laboratory of Pattern Recognition, Institute of Automation, Chinese Academy of Sciences, Beijing, China.; School of Artificial Intelligence, University of Chinese Academy of Sciences, Beijing, China.
Liu S; Brainnetome Center and National Laboratory of Pattern Recognition, Institute of Automation, Chinese Academy of Sciences, Beijing, China.; School of Artificial Intelligence, University of Chinese Academy of Sciences, Beijing, China.; Center for Excellence in Brain Science and Intelligence Technology, Chinese Academy of Sciences, Shanghai, China.
Wang M; Brainnetome Center and National Laboratory of Pattern Recognition, Institute of Automation, Chinese Academy of Sciences, Beijing, China.; School of Artificial Intelligence, University of Chinese Academy of Sciences, Beijing, China.; Center for Excellence in Brain Science and Intelligence Technology, Chinese Academy of Sciences, Shanghai, China.
Sun Y; Brainnetome Center and National Laboratory of Pattern Recognition, Institute of Automation, Chinese Academy of Sciences, Beijing, China.; School of Artificial Intelligence, University of Chinese Academy of Sciences, Beijing, China.; Center for Excellence in Brain Science and Intelligence Technology, Chinese Academy of Sciences, Shanghai, China.
Song M; Brainnetome Center and National Laboratory of Pattern Recognition, Institute of Automation, Chinese Academy of Sciences, Beijing, China.; School of Artificial Intelligence, University of Chinese Academy of Sciences, Beijing, China.
Li P; Institute of Mental Health, Peking University Sixth Hospital, Beijing, China.; Key Laboratory of Mental Health, Ministry of Health, and National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Beijing, China.
Chen J; Department of Radiology, Renmin Hospital of Wuhan University, Wuhan, China.
Chen Y; Department of Psychiatry, Xijing Hospital, The Fourth Military Medical University, Xi'an, China.
Wang H; Department of Psychiatry, Xijing Hospital, The Fourth Military Medical University, Xi'an, China.
Liu W; Department of Psychiatry, Xijing Hospital, The Fourth Military Medical University, Xi'an, China.
Li Z; Zhumadian Psychiatric Hospital, Zhumadian, China.
Yang Y; Department of Psychiatry, Henan Mental Hospital, The Second Affiliated Hospital of Xinxiang Medical University, Xinxiang, China.; Henan Key Lab of Biological Psychiatry of Xinxiang Medical University, International Joint Research Laboratory for Psychiatry and Neuroscience of Henan, Xinxiang, China.
Guo H; Zhumadian Psychiatric Hospital, Zhumadian, China.
Wan P; Zhumadian Psychiatric Hospital, Zhumadian, China.
Lv L; Department of Psychiatry, Henan Mental Hospital, The Second Affiliated Hospital of Xinxiang Medical University, Xinxiang, China.; Henan Key Lab of Biological Psychiatry of Xinxiang Medical University, International Joint Research Laboratory for Psychiatry and Neuroscience of Henan, Xinxiang, China.
Lu L; Institute of Mental Health, Peking University Sixth Hospital, Beijing, China.; Key Laboratory of Mental Health, Ministry of Health, and National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Beijing, China.
Yan J; Institute of Mental Health, Peking University Sixth Hospital, Beijing, China.; Key Laboratory of Mental Health, Ministry of Health, and National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Beijing, China.
Song Y; Institute of Mental Health, Peking University Sixth Hospital, Beijing, China.; Key Laboratory of Mental Health, Ministry of Health, and National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Beijing, China.
Wang H; Department of Psychiatry, Renmin Hospital of Wuhan University, Wuhan, China.
Zhang H; Department of Psychiatry, Henan Mental Hospital, The Second Affiliated Hospital of Xinxiang Medical University, Xinxiang, China.; Henan Key Lab of Biological Psychiatry of Xinxiang Medical University, International Joint Research Laboratory for Psychiatry and Neuroscience of Henan, Xinxiang, China.; Department of Psychology, Xinxiang Medical University, Xinxiang, China.
Wu H; The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China.
Ning Y; The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China.
Du Y; School of Computer and Information Technology, Shanxi University, Taiyuan, China.
Cheng Y; Department of Psychiatry, First Affiliated Hospital of Kunming Medical University, Kunming, China.
Xu J; Department of Psychiatry, First Affiliated Hospital of Kunming Medical University, Kunming, China.
Xu X; Department of Psychiatry, First Affiliated Hospital of Kunming Medical University, Kunming, China.
Zhang D; Institute of Mental Health, Peking University Sixth Hospital, Beijing, China.; Key Laboratory of Mental Health, Ministry of Health, and National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Beijing, China.; Center for Life Sciences/ PKU-IDG/McGovern Institute for Brain Research, Peking University, Beijing, China.
Wang X; School of Artificial Intelligence, University of Chinese Academy of Sciences, Beijing, China.; Center for Excellence in Brain Science and Intelligence Technology, Chinese Academy of Sciences, Shanghai, China.; State Key Laboratory of Brain and Cognitive Science, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.
Jiang T; Brainnetome Center and National Laboratory of Pattern Recognition, Institute of Automation, Chinese Academy of Sciences, Beijing, China. .; School of Artificial Intelligence, University of Chinese Academy of Sciences, Beijing, China. .; Center for Excellence in Brain Science and Intelligence Technology, Chinese Academy of Sciences, Shanghai, China. .; Innovation Academy for Artificial Intelligence, Chinese Academy of Sciences, Beijing, China. .; Key Laboratory for Neuro Information of Ministry of Education, School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, China. .; Queensland Brain Institute, University of Queensland, Brisbane, Australia. .
Liu B; Brainnetome Center and National Laboratory of Pattern Recognition, Institute of Automation, Chinese Academy of Sciences, Beijing, China. .; School of Artificial Intelligence, University of Chinese Academy of Sciences, Beijing, China. .; Center for Excellence in Brain Science and Intelligence Technology, Chinese Academy of Sciences, Shanghai, China. .; Innovation Academy for Artificial Intelligence, Chinese Academy of Sciences, Beijing, China. .; Pokaż więcej
Źródło :: Nature medicine [Nat Med] 2020 Apr; Vol. 26 (4), pp. 558-565. Date of Electronic Publication: 2020 Mar 23.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't; Validation Study
MeSH Terms :: Biomarkers*/analysis
Corpus Striatum/*diagnostic imaging
Corpus Striatum/*physiopathology
Neuroimaging/*methods
Schizophrenia/*diagnosis
Adolescent ; Adult ; Antipsychotic Agents/therapeutic use ; Biomarkers, Pharmacological/analysis ; Brain Mapping/methods ; Case-Control Studies ; Female ; Functional Neuroimaging/methods ; Humans ; Magnetic Resonance Imaging/methods ; Male ; Middle Aged ; Reproducibility of Results ; Research Design ; Schizophrenia/drug therapy ; Schizophrenia/physiopathology ; Sensitivity and Specificity ; Support Vector Machine ; Young Adult
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 12 12.

Tytuł :: Exploration into biomarker potential of region-specific brain gene co-expression networks.
Autorzy :: Hang Y; Department of Genetics and Biochemistry, Clemson University, Clemson, 29634, USA.
Aburidi M; Biomedical Data Science and Informatics Program, Clemson University, Clemson, 29634, USA.
Husain B; Biomedical Data Science and Informatics Program, Clemson University, Clemson, 29634, USA.
Hickman AR; Department of Genetics and Biochemistry, Clemson University, Clemson, 29634, USA.
Poehlman WL; Department of Genetics and Biochemistry, Clemson University, Clemson, 29634, USA.
Feltus FA; Department of Genetics and Biochemistry, Clemson University, Clemson, 29634, USA. .; Biomedical Data Science and Informatics Program, Clemson University, Clemson, 29634, USA. .; Center for Human Genetics, Clemson University, Clemson, 29634, USA. .; Pokaż więcej
Źródło :: Scientific reports [Sci Rep] 2020 Oct 13; Vol. 10 (1), pp. 17089. Date of Electronic Publication: 2020 Oct 13.
Typ publikacji :: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Validation Study
MeSH Terms :: Gene Regulatory Networks*
Biomarkers/*metabolism
Brain/*metabolism
Biomarkers, Tumor/genetics ; Biomarkers, Tumor/metabolism ; Brain Neoplasms/genetics ; Brain Neoplasms/metabolism ; Databases, Genetic ; Gene Expression Profiling ; Genetic Markers ; Humans ; Models, Genetic ; Models, Neurological ; Mutation ; Neural Networks, Computer ; Tissue Distribution
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 13 13.

Tytuł :: Prodiamesa olivacea: de novo biomarker genes in a potential sentinel organism for ecotoxicity studies in natural scenarios.
Autorzy :: Llorente L; Biology and Environmental Toxicology Group, Faculty of Sciences, Universidad Nacional de Educación a Distancia (UNED), Paseo de la Senda del Rey 9, 28040 Madrid, Spain.
Herrero Ó; Biology and Environmental Toxicology Group, Faculty of Sciences, Universidad Nacional de Educación a Distancia (UNED), Paseo de la Senda del Rey 9, 28040 Madrid, Spain.
Aquilino M; Biology and Environmental Toxicology Group, Faculty of Sciences, Universidad Nacional de Educación a Distancia (UNED), Paseo de la Senda del Rey 9, 28040 Madrid, Spain.
Planelló R; Biology and Environmental Toxicology Group, Faculty of Sciences, Universidad Nacional de Educación a Distancia (UNED), Paseo de la Senda del Rey 9, 28040 Madrid, Spain. Electronic address: .; Pokaż więcej
Źródło :: Aquatic toxicology (Amsterdam, Netherlands) [Aquat Toxicol] 2020 Oct; Vol. 227, pp. 105593. Date of Electronic Publication: 2020 Aug 13.
Typ publikacji :: Journal Article
MeSH Terms :: Environmental Biomarkers*
Biomarkers/*metabolism
Chironomidae/*physiology
Water Pollutants, Chemical/*toxicity
Animals ; Benzhydryl Compounds ; Benzophenones ; Chironomidae/drug effects ; Ecosystem ; Larva/drug effects ; Phenols ; Phthalic Acids ; Rivers ; Sentinel Species ; Xenobiotics/metabolism
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 14 14.

Tytuł :: Causes behind error rates for predictive biomarker testing: the utility of sending post-EQA surveys.
Autorzy :: Keppens C; Department of Public Health and Primary Care, Biomedical Quality Assurance Research Unit, University of Leuven, Kapucijnenvoer 35 block d, 1st floor, box 7001, 3000, Leuven, Belgium.
Schuuring E; Department of Pathology, University of Groningen, University Medical Center Groningen (UMCG), (HPC EA10), Hanzeplein 1, PO Box 30001, 9700 RB, Groningen, The Netherlands.
Dequeker EMC; Department of Public Health and Primary Care, Biomedical Quality Assurance Research Unit, University of Leuven, Kapucijnenvoer 35 block d, 1st floor, box 7001, 3000, Leuven, Belgium. .; Pokaż więcej
Źródło :: Virchows Archiv : an international journal of pathology [Virchows Arch] 2021 May; Vol. 478 (5), pp. 995-1006. Date of Electronic Publication: 2020 Nov 23.
Typ publikacji :: Journal Article
MeSH Terms :: Biomarkers, Tumor*/analysis
Biomarkers, Tumor*/genetics
Carcinoma, Non-Small-Cell Lung/*diagnosis
Colorectal Neoplasms/*diagnosis
Immunohistochemistry/*standards
In Situ Hybridization, Fluorescence/*standards
Lung Neoplasms/*diagnosis
Quality Indicators, Health Care/*standards
Carcinoma, Non-Small-Cell Lung/chemistry ; Carcinoma, Non-Small-Cell Lung/genetics ; Colorectal Neoplasms/chemistry ; Colorectal Neoplasms/genetics ; Feasibility Studies ; Health Care Surveys ; Humans ; Lung Neoplasms/chemistry ; Lung Neoplasms/genetics ; Observer Variation ; Predictive Value of Tests ; Quality Assurance, Health Care/standards ; Quality Improvement/standards ; Reproducibility of Results
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 15 15.

Tytuł :: Identification of Long Noncoding RNA Biomarkers for Hepatocellular Carcinoma Using Single-Sample Networks.
Autorzy :: Yu X; School of Sciences, Shanghai Institute of Technology, Shanghai 201418, China.
Zhang J; Key Laboratory of Systems Biology, State Key Laboratory of Cell Biology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai 200031, China.
Yang R; School of Sciences, Shanghai Institute of Technology, Shanghai 201418, China.
Li C; School of Mathematics and Statistics, Hainan Normal University, Haikou 571158, China.; Pokaż więcej
Źródło :: BioMed research international [Biomed Res Int] 2020 Nov 14; Vol. 2020, pp. 8579651. Date of Electronic Publication: 2020 Nov 14 (Print Publication: 2020).
Typ publikacji :: Journal Article
MeSH Terms :: Gene Expression Regulation, Neoplastic*
Biomarkers, Tumor/*genetics
Carcinoma, Hepatocellular/*genetics
Liver Neoplasms/*genetics
RNA, Long Noncoding/*genetics
Algorithms ; Biomarkers ; Carcinoma, Hepatocellular/mortality ; Female ; Gene Expression Profiling ; Humans ; Kaplan-Meier Estimate ; Liver Neoplasms/mortality ; Male ; Prognosis ; Proportional Hazards Models ; RNA-Seq ; ROC Curve ; Regression Analysis ; Risk
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 16 16.

Tytuł :: Noninvasive Early Identification of Therapeutic Benefit from Immune Checkpoint Inhibition.
Autorzy :: Nabet BY; Department of Radiation Oncology, Stanford University, Stanford, CA, USA; Stanford Cancer Institute, Stanford University, Stanford, CA, USA.
Esfahani MS; Division of Oncology, Department of Medicine, Stanford Cancer Institute, Stanford University, Stanford, CA, USA.
Moding EJ; Department of Radiation Oncology, Stanford University, Stanford, CA, USA; Stanford Cancer Institute, Stanford University, Stanford, CA, USA.
Hamilton EG; Department of Radiation Oncology, Stanford University, Stanford, CA, USA; Program in Cancer Biology, Stanford University, Stanford, CA, USA.
Chabon JJ; Department of Radiation Oncology, Stanford University, Stanford, CA, USA; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA, USA.
Rizvi H; Druckenmiller Center for Lung Cancer Research, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Steen CB; Stanford Cancer Institute, Stanford University, Stanford, CA, USA.
Chaudhuri AA; Department of Radiation Oncology, Department of Genetics, Washington University School of Medicine, St. Louis, MO, USA.
Liu CL; Stanford Cancer Institute, Stanford University, Stanford, CA, USA; Division of Oncology, Department of Medicine, Stanford Cancer Institute, Stanford University, Stanford, CA, USA.
Hui AB; Department of Radiation Oncology, Stanford University, Stanford, CA, USA; Stanford Cancer Institute, Stanford University, Stanford, CA, USA.
Almanza D; Department of Radiation Oncology, Stanford University, Stanford, CA, USA; Program in Cancer Biology, Stanford University, Stanford, CA, USA.
Stehr H; Department of Pathology, Stanford University, Stanford, CA, USA.
Gojenola L; Department of Pathology, Stanford University, Stanford, CA, USA.
Bonilla RF; Department of Radiation Oncology, Stanford University, Stanford, CA, USA.
Jin MC; Division of Oncology, Department of Medicine, Stanford Cancer Institute, Stanford University, Stanford, CA, USA.
Jeon YJ; Department of Radiation Oncology, Stanford University, Stanford, CA, USA; Stanford Cancer Institute, Stanford University, Stanford, CA, USA; Department of Integrative Biotechnology, Sungkyunkwan University, Suwon, Republic of Korea.
Tseng D; Division of Oncology, Department of Medicine, Stanford Cancer Institute, Stanford University, Stanford, CA, USA.
Liu C; Ludwig Collaborative and Swim Across America Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Merghoub T; Ludwig Collaborative and Swim Across America Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Cornell School of Medicine, New York, NY, USA; Parker Institute for Cancer Immunotherapy at MSK, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Neal JW; Stanford Cancer Institute, Stanford University, Stanford, CA, USA; Division of Oncology, Department of Medicine, Stanford Cancer Institute, Stanford University, Stanford, CA, USA.
Wakelee HA; Stanford Cancer Institute, Stanford University, Stanford, CA, USA; Division of Oncology, Department of Medicine, Stanford Cancer Institute, Stanford University, Stanford, CA, USA.
Padda SK; Stanford Cancer Institute, Stanford University, Stanford, CA, USA; Division of Oncology, Department of Medicine, Stanford Cancer Institute, Stanford University, Stanford, CA, USA.
Ramchandran KJ; Stanford Cancer Institute, Stanford University, Stanford, CA, USA; Division of Oncology, Department of Medicine, Stanford Cancer Institute, Stanford University, Stanford, CA, USA.
Das M; Stanford Cancer Institute, Stanford University, Stanford, CA, USA; Division of Oncology, Department of Medicine, Stanford Cancer Institute, Stanford University, Stanford, CA, USA; Department of Medicine, VA Palo Alto Health Care System, Palo Alto, CA, USA.
Plodkowski AJ; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Yoo C; Department of Radiation Oncology, Stanford University, Stanford, CA, USA.
Chen EL; Department of Radiation Oncology, Stanford University, Stanford, CA, USA.
Ko RB; Department of Radiation Oncology, Stanford University, Stanford, CA, USA.
Newman AM; Stanford Cancer Institute, Stanford University, Stanford, CA, USA; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA, USA; Department of Biomedical Data Science, Stanford University, Stanford, CA, USA.
Hellmann MD; Druckenmiller Center for Lung Cancer Research, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Cornell School of Medicine, New York, NY, USA; Parker Institute for Cancer Immunotherapy at MSK, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: .
Alizadeh AA; Stanford Cancer Institute, Stanford University, Stanford, CA, USA; Division of Oncology, Department of Medicine, Stanford Cancer Institute, Stanford University, Stanford, CA, USA; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA, USA. Electronic address: .
Diehn M; Department of Radiation Oncology, Stanford University, Stanford, CA, USA; Stanford Cancer Institute, Stanford University, Stanford, CA, USA; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA, USA. Electronic address: .; Pokaż więcej
Źródło :: Cell [Cell] 2020 Oct 15; Vol. 183 (2), pp. 363-376.e13. Date of Electronic Publication: 2020 Oct 01.
Typ publikacji :: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :: Biomarkers, Pharmacological/*blood
Circulating Tumor DNA/*analysis
Immune Checkpoint Inhibitors/*therapeutic use
Adult ; Antineoplastic Agents, Immunological/pharmacology ; B7-H1 Antigen/immunology ; B7-H1 Antigen/metabolism ; Biomarkers, Tumor/genetics ; CD8-Positive T-Lymphocytes/pathology ; Carcinoma, Non-Small-Cell Lung/pathology ; Circulating Tumor DNA/genetics ; Female ; Humans ; Immune Checkpoint Inhibitors/immunology ; Immune Checkpoint Inhibitors/metabolism ; Immunotherapy/methods ; Lung Neoplasms/pathology ; Male ; Middle Aged ; Programmed Cell Death 1 Receptor/metabolism
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 17 17.

Tytuł :: Specific Biomarker Expression Patterns in the Diagnosis of Residual and Recurrent Endometrial Precancers After Progestin Treatment: A Longitudinal Study.
Autorzy :: Chen H; Departments of Pathology.
Lucas E; Departments of Pathology.
Strickland AL; Departments of Pathology.
Carrick K; Departments of Pathology.
Gwin K; Departments of Pathology.
Castrillon DH; Departments of Pathology.; Obstetrics and Gynecology.; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX.
Rivera-Colon G; Departments of Pathology.
Niu S; Departments of Pathology.
Molberg KH; Departments of Pathology.
Zheng W; Departments of Pathology.; Obstetrics and Gynecology.; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX.; Pokaż więcej
Źródło :: The American journal of surgical pathology [Am J Surg Pathol] 2020 Oct; Vol. 44 (10), pp. 1429-1439.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Biomarkers, Tumor/*analysis
Endometrial Hyperplasia/*diagnosis
Endometrial Hyperplasia/*drug therapy
Endometrium/*drug effects
Progesterone Congeners/*therapeutic use
Adult ; Aged ; Biomarkers/analysis ; Endometrium/pathology ; Female ; Humans ; Longitudinal Studies ; Middle Aged ; PAX2 Transcription Factor/analysis ; PTEN Phosphohydrolase/analysis ; Precancerous Conditions/diagnosis ; Precancerous Conditions/drug therapy ; Recurrence
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 18 18.

Tytuł :: The Effects of Gamma Irradiation on Chemical Biomarker Recovery from Mixed Chemical/Biological Threat Exposure Specimens.
Autorzy :: Isenberg SL; Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA.
Carter MD; Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA.
Moon JL; Division of Scientific Resources, National Center for Emerging & Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA.
Laughlin S; Oak Ridge Institute for Science and Education at the Centers for Disease Control and Prevention, Atlanta, GA.
Petway M; Division of Scientific Resources, National Center for Emerging & Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA.
Mojica MA; Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA.
Rood JE; Epidemiology Elective Program at the Centers for Disease Control and Prevention, Atlanta, GA.
Gursky AK; Oak Ridge Institute for Science and Education at the Centers for Disease Control and Prevention, Atlanta, GA.
Sheppard CI; Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA.
Bagarozzi DA; Division of Scientific Resources, National Center for Emerging & Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA.
Pirkle JL; Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA.
Johnson RC; Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA.; Pokaż więcej
Źródło :: The journal of applied laboratory medicine [J Appl Lab Med] 2020 Mar 01; Vol. 5 (2), pp. 273-280.
Typ publikacji :: Journal Article; Research Support, U.S. Gov't, P.H.S.
MeSH Terms :: Biomarkers*
Gamma Rays*
Sterilization*/methods
Alkaloids/analysis ; Alkaloids/chemistry ; Biomarkers, Pharmacological/analysis ; Biomarkers, Pharmacological/chemistry ; Chemical Safety ; Chromatography, High Pressure Liquid ; Consumer Product Safety ; Equipment Safety ; Indole Alkaloids/analysis ; Indole Alkaloids/chemistry ; Pilot Projects ; Pyridones/analysis ; Pyridones/chemistry ; Quality Control ; Radiation Dosage
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 19 19.

Tytuł :: Identification of miR‑25‑3p as a tumor biomarker: Regulation of cellular functions via TOB1 in breast cancer.
Autorzy :: Zhao T; Institute of Basic Research In Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, P.R. China.
Meng W; Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, P.R. China.
Chin Y; Integrated Traditional Chinese Medicine and Western Medicine Department, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, P.R. China.
Gao L; Department of Traditional Chinese Medicine, Tianjin Central Hospital of Gynecology Obstetrics, Tianjin 300052, P.R. China.
Yang X; School of Acupuncture and Moxibustion and Tuina, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, P.R. China.
Sun S; School of Acupuncture and Moxibustion and Tuina, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, P.R. China.
Pan X; School of Acupuncture and Moxibustion and Tuina, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, P.R. China.
He L; Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, P.R. China.; Pokaż więcej
Źródło :: Molecular medicine reports [Mol Med Rep] 2021 Jun; Vol. 23 (6). Date of Electronic Publication: 2021 Mar 31.
Typ publikacji :: Journal Article
MeSH Terms :: Biomarkers, Tumor/*genetics
Breast Neoplasms/*genetics
Intracellular Signaling Peptides and Proteins/*genetics
MicroRNAs/*genetics
Tumor Suppressor Proteins/*genetics
Adult ; Aged ; Biomarkers, Tumor/blood ; Biomarkers, Tumor/metabolism ; Breast Neoplasms/metabolism ; Breast Neoplasms/pathology ; Female ; Gene Expression Regulation, Neoplastic ; Humans ; Intracellular Signaling Peptides and Proteins/metabolism ; Lymphatic Metastasis ; MCF-7 Cells ; MicroRNAs/blood ; MicroRNAs/metabolism ; Middle Aged ; Tumor Suppressor Proteins/metabolism ; Up-Regulation
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 20 20.

Tytuł :: Aberrant expression of m A mRNA methylation regulators in colorectal adenoma and adenocarcinoma.
Autorzy :: Kuai D; Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, National Clinical Research Center for Digestive Disease, Beijing Digestive Disease Center, Beijing Key Laboratory for Precancerous Lesion of Digestive Disease, Beijing 100050, PR China; Department of Gastroenterology, Beijing Luhe Hospital, Capital Medical University, 101149, PR China.
Zhu S; Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, National Clinical Research Center for Digestive Disease, Beijing Digestive Disease Center, Beijing Key Laboratory for Precancerous Lesion of Digestive Disease, Beijing 100050, PR China.
Shi H; Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, National Clinical Research Center for Digestive Disease, Beijing Digestive Disease Center, Beijing Key Laboratory for Precancerous Lesion of Digestive Disease, Beijing 100050, PR China.
Yang R; Clinical Research Management Center, The Fifth Medical Center of PLA General Hospital, Beijing 100039, PR China.
Liu T; Department of Pathology, Beijing Luhe Hospital, Capital Medical University, Beijing 101149, PR China.
Liu H; Department of Pathology, Beijing Luhe Hospital, Capital Medical University, Beijing 101149, PR China.
Min L; Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, National Clinical Research Center for Digestive Disease, Beijing Digestive Disease Center, Beijing Key Laboratory for Precancerous Lesion of Digestive Disease, Beijing 100050, PR China. Electronic address: .
Zhang S; Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, National Clinical Research Center for Digestive Disease, Beijing Digestive Disease Center, Beijing Key Laboratory for Precancerous Lesion of Digestive Disease, Beijing 100050, PR China. Electronic address: .; Pokaż więcej
Źródło :: Life sciences [Life Sci] 2021 May 15; Vol. 273, pp. 119258. Date of Electronic Publication: 2021 Feb 23.
Typ publikacji :: Journal Article
MeSH Terms :: DNA Methylation*
Gene Expression Regulation, Neoplastic*
Adenocarcinoma/*pathology
Adenoma/*pathology
Adenosine/*analogs & derivatives
Biomarkers, Tumor/*metabolism
Colorectal Neoplasms/*pathology
RNA, Messenger/*chemistry
Adenocarcinoma/genetics ; Adenocarcinoma/metabolism ; Adenoma/genetics ; Adenoma/metabolism ; Adenosine/chemistry ; Biomarkers, Tumor/genetics ; Case-Control Studies ; Colorectal Neoplasms/genetics ; Colorectal Neoplasms/metabolism ; Eukaryotic Initiation Factor-3/genetics ; Eukaryotic Initiation Factor-3/metabolism ; Female ; Follow-Up Studies ; Gene Expression Profiling ; Humans ; Male ; Nerve Tissue Proteins/genetics ; Nerve Tissue Proteins/metabolism ; Prognosis ; RNA Splicing Factors/genetics ; RNA Splicing Factors/metabolism ; RNA, Messenger/genetics ; RNA-Binding Proteins/genetics ; RNA-Binding Proteins/metabolism
: Czasopismo naukowe

Szczegóły

Informacja

Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""BIOMARKERS"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język